Northwestern Inventor: SwiftScale Biologics seeks to bring life-saving drugs to patients faster than previously possible. Specifically, we are using cutting-edge cell-free and bacterial production platforms to rapidly produce protein therapeutics. Our technology is faster and cheaper than traditional manufacturing approaches, reducing time and cost to reach clinical trials and market.
McCormick School of Engineering
Department of Chemical and Biological Engineering
Since the outbreak, SwiftScale has been focused on scaling up production of COVID-19 antiviral therapies using antibodies developed in partner labs and companies.